Carcinoma of Unknown Primary
📧 Sign up to get email alerts when something new happens for Carcinoma of Unknown Primary.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-08-28Clinical Trial Update: Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors [Phase 1]
A Phase 1 trial from Dartmouth-Hitchcock Medical Center evaluated combining chemotherapy with filgrastim in patients with advanced solid tum…
-
CLINICAL_TRIALS research · 2013-08-07Clinical Trial Update: Chemotherapy in Treating Patients With Cancer of Unknown Primary Origin [Phase 3]
A Phase 3 clinical trial update about using chemotherapy to treat patients with carcinoma of unknown primary.
-
CLINICAL_TRIALS trial_result · 2013-07-25Clinical Trial Update: Radiation Therapy and Chemotherapy in Treating Patients With Head and Neck Cancer [Phase 3]
Phase 3 trial of radiation therapy combined with chemotherapy for head and neck cancer has completed. The update does not provide efficacy r…
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: Irinotecan in Treating Patients With Advanced Neuroendocrine Tumors [Phase 2]
A Phase 2 trial of irinotecan in patients with advanced neuroendocrine tumors, including carcinoma of unknown primary and neuroendocrine car…
-
CLINICAL_TRIALS trial_result · 2013-05-03Clinical Trial Update: Gemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Carcinoma of Unknown Primary Site [Phase 3]
Phase 3 randomized trial evaluating gemcitabine/irinotecan/Gefitinib versus paclitaxel/carboplatin/etoposide/Gefitinib in carcinoma of unkno…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-04-17Clinical Trial Update: Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Cancer. [Phase 2]
A Phase 2 clinical trial evaluating the combination of chemotherapy plus peripheral stem cell transplantation in patients with metastatic ca…
-
CLINICAL_TRIALS trial_result · 2010-09-17Clinical Trial Update: Bevacizumab and Erlotinib in the Treatment of Patients With Carcinoma of Unknown Primary Site [Phase 2]
Phase 2 trial evaluating the combination of Bevacizumab and Erlotinib in patients with carcinoma of unknown primary; the study status is com…
-
CLINICAL_TRIALS trial_result · 2009-12-04Clinical Trial Update: SU5416 in Treating Patients With Advanced or Recurrent Cancer of the Head and Neck [Phase 2]
Phase 2 trial evaluated SU5416 (semaxanib), an anti-angiogenic agent, in patients with advanced or recurrent head and neck cancer, carcinoma…
-
CLINICAL_TRIALS trial_result · 2008-01-10Clinical Trial Update: Combination of Carboplatin, Gemcitabine, and Capecitabine in Patients With Carcinoma of Unknown Primary Site [Phase 2]
This update notes the termination of a Phase 2 study evaluating Carboplatin, Gemcitabine, and Capecitabine in carcinoma of unknown primary.
-
CLINICAL_TRIALS trial_result · 2006-09-08Clinical Trial Update: Trial Comparing Cisplatin With or Without Gemcitabine in Patients With Carcinoma of Unknown Primary [Phase 3]
A phase 3 clinical trial compares cisplatin alone versus cisplatin plus gemcitabine in patients with carcinoma of unknown primary; the trial…